(1) Ji, Guanjie.Recent advances of novel targeted drug delivery systems based on natural medicine monomers against hepatocellular carcinoma.Heliyon.2024,10 (2)
(2) Hao, Yanyun.Site-specific nanoswitch circumventing immune resistance via activating TLR and inhibiting PD-L1/PD-1 axis.Journal of Controlled Release.2023,361 :64-76
(3) Hao, Yanyun.Ferrocene-conjugated polymeric platform via amide bond formation facilitates enhanced in situ fenton reaction and robust immune responses in combination with toll-like receptor 7/8 agonist.Chemical Engineering Journal.2023,472
(4) Lingling Huang .The Role of Toll-like Receptor Agonists and Their Nanomedicines for Tumor Immunotherapy.PHARMACEUTICS.2022 (6)
(5) In Situ Tumor Vaccination with Calcium-Linked Degradable Coacervate Nanocomplex Co-Delivering Photosensitizer and TLR7/8 Agonist to Trigger Effective Anti-Tumor Immune Responses.Advanced Healthcare Materials.2022 (11)
(6) 李慧.Imidazoquinoline-Conjugated Degradable Coacervate Conjugate for Local Cancer Immunotherapy.ACS BIOMATERIALS-SCIENCE & ENGINEERING.2020 (6)
(7) Sequential acid/reduction response of triblock copolymeric nanomicelles to release camptothecin and toll-like receptor 7/8 agonist for orchestrated chemoimmunotherapy.Journal of Nanobiotechnology.2022 (1)
1. 一种咪喹莫特前药纳米粒及其制备方法和应用
2. 一种聚多巴胺载吡菲尼酮纳米粒及其制备方法和应用
3. 一种具有化疗-免疫功能的混合三嵌段胶束及其制备方法和应用
4. 一种具有光热-化疗-免疫功能的纳米粒及其制备方法和应用
5. 一种多功能纳米复合物及其制备方法和应用
6. 一种二茂铁和TLR7/8激动剂共连接纳米粒及其制备方法和应用
7. 一种骨靶向共递送硼替佐米和泊马度胺纳米复合物及其制备方法和应用
1. 肿瘤微环境响应型蛋白降解剂-膜固定蛋白嵌合体偶联前药用于清除衰老细胞并增强放射免疫治疗研究, 2024/12/04-2027/12/31
2. （包干项目）基于纳米杂合中性粒细胞的整合应激稳态“破坏加速器”逆转结直肠癌治疗耐受研究, 2024/08/23-2027/12/31
